Risk Factors and Prediction Score of ARDS After Cardiac Surgery

January 28, 2021 updated by: Guangfa Zhu, Beijing Anzhen Hospital
Acute respiratory distress syndrome following cardiac surgery severely affects the prognosis of patients; the mortality is up to 40%. Although experience many years of research and exploration, the effective methods for the treatment of acute respiratory distress syndrome is still relatively limited at present, including lung protective mechanical ventilation respiratory support, fluid management, glucocorticoid and other integrated organ function maintenance measures. It is currently the research of acute respiratory distress syndrome aims at the early discovery and takes effective measures to prevent its occurrence, hoping to improve the prognosis of patients. According to risk factors is established through the analysis of lung injury score early warning system, the early identification of acute respiratory distress syndrome patients at high risk, before the occurrence of acute respiratory distress syndrome take corresponding preventive measures can effectively reduce the incidence rate and mortality. So far, domestic and foreign research on the establishment of acute respiratory distress syndrome scoring early warning system is less. Cardiac surgery has significant characteristics, type of operation, location, operation, intraoperative blood transfusion and oxygenation, postoperative factors, are likely to be the factors of acute respiratory distress syndrome. As far as investigators know, so far there are few specialized for acute respiratory distress syndrome predicting lung injury after cardiac surgery. This study will be completed after the implementation of individualized dynamic lung injury score evaluation of cardiac surgery patients, identification of high-risk acute respiratory distress syndrome patients, to assist clinicians in early decision, take preventive measures. This study will improve the prognosis of acute respiratory distress syndrome patients after cardiac surgery; it is of great significance to improve the level of intensive care after cardiac surgery.

Study Overview

Study Type

Observational

Enrollment (Actual)

1333

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100029
        • Department of Respiratory and Critical Care Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients of cardiac surgery in Beijing Anzhen hospital

Description

Inclusion Criteria:

  • Retrospective group: cardiac surgery patients accepted from Jan 2013 to Dec 2015
  • Prospective group: cardiac surgery patients accepted from 2017 January to December

Exclusion Criteria:

  • refused to participate in the study
  • age less than 18 years old
  • before operation performed mechanical ventilation
  • before operation underwent IABP treatment
  • before operation continuous renal replacement therapy
  • before operation undergoing in vitro membrane oxygenator treatment
  • before operation has the pulmonary imaging showed bilateral pulmonary diffuse exudation of interstitial pneumonia, pulmonary infection or respiratory failure
  • the major trauma, sepsis, aspiration, shock, acute heart failure
  • before operation diagnosed as malignant tumor
  • Incomplete data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ARDS
ARDS patients after cardiac surgery
This is a clinical observational study, no intervention was included.
non-ARDS
non-ARDS patients after cardiac surgery
This is a clinical observational study, no intervention was included.
propective group
patients of cardiac surgery including ARDS and non-ARDS patients
This is a clinical observational study, no intervention was included.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The number of acute respiratory distress syndrome following cardiac surgery in Anzhen hospital during Jan 2013 to Dec 2015.
Time Frame: up to 12months
up to 12months
The number of patients of cardiac surgery in Anzhen hospital during Jan 2013 to Dec 2015.
Time Frame: up to 12months
up to 12months
The number of acute respiratory distress syndrome following cardiac surgery in Anzhen hospital during Jan 2017 to Dec 2017.
Time Frame: up to 12months
up to 12months
The number of patients of cardiac surgery in Anzhen hospital during Jan 2017 to Dec 2017.
Time Frame: up to 12months
up to 12months
The number of diabetic patients in ARDS group.
Time Frame: up to 1 month
up to 1 month
The number of diabetic patients in non-ARDS group.
Time Frame: up to 1 month
up to 1 month
The number of chronic obstructive pulmonary disease patients in ARDS group.
Time Frame: up to 1 month
up to 1 month
The number of chronic obstructive pulmonary disease patients in non-ARDS group.
Time Frame: up to 1 month
up to 1 month
The type of operation in ARDS group.
Time Frame: up to 1 month
up to 1 month
The type of operation in non-ARDS group.
Time Frame: up to 1 month
up to 1 month
The body mass index in ARDS group.
Time Frame: up to 1 month
up to 1 month
The body mass index in non-ARDS group.
Time Frame: up to 1 month
up to 1 month
The heart function in ARDS group before operation.
Time Frame: up to 1 month
up to 1 month
The heart function in non-ARDS group before operation.
Time Frame: up to 1 month
up to 1 month
The oxygenation in ARDS group before operation.
Time Frame: up to 1 month
up to 1 month
The oxygenation in non-ARDS group before operation.
Time Frame: up to 1 month
up to 1 month
The drug taken by patients in ARDS group.
Time Frame: up to 1 month
up to 1 month
The drug taken by patients in non-ARDS group.
Time Frame: up to 1 month
up to 1 month
The nutrition situation of patients in ARDS group.
Time Frame: up to 1 month
up to 1 month
The nutrition situation of patients in non-ARDS group.
Time Frame: up to 1 month
up to 1 month
The process of operation in ARDS group.
Time Frame: up to 1 month
up to 1 month
The process of operation in non-ARDS group.
Time Frame: up to 1 month
up to 1 month
The blood transfusion of patients during operation in ARDS group.
Time Frame: up to 1 month
up to 1 month
The blood transfusion of patients during operation in non-ARDS group.
Time Frame: up to 1 month
up to 1 month
The oxygenation of patients during operation in ARDS group.
Time Frame: up to 1 month
up to 1 month
The oxygenation of patients during operation in non-ARDS group.
Time Frame: up to 1 month
up to 1 month
The drug taken by patients after operation in ARDS group.
Time Frame: up to 1 month
up to 1 month
The drug taken by patients after operation in non-ARDS group.
Time Frame: up to 1 month
up to 1 month
The oxygenation of patients after operation in ARDS group.
Time Frame: up to 1 month
up to 1 month
The oxygenation of patients after operation in non-ARDS group.
Time Frame: up to 1 month
up to 1 month
The situation of mechanical ventilation of patients after operation in ARDS group.
Time Frame: up to 1 month
up to 1 month
The situation of mechanical ventilation of patients after operation in non-ARDS group.
Time Frame: up to 1 month
up to 1 month

Secondary Outcome Measures

Outcome Measure
Time Frame
The mortality of acute respiratory distress syndrome following cardiac surgery in Anzhen hospital .
Time Frame: up to 1months
up to 1months
The morbidity of acute respiratory distress syndrome following cardiac surgery in Anzhen hospital .
Time Frame: up to 1months
up to 1months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Guangfa Zhu, Department of Respiratory and Critical Care Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2017

Primary Completion (Actual)

September 30, 2017

Study Completion (Actual)

September 30, 2017

Study Registration Dates

First Submitted

April 25, 2016

First Submitted That Met QC Criteria

April 29, 2016

First Posted (Estimate)

May 3, 2016

Study Record Updates

Last Update Posted (Actual)

February 1, 2021

Last Update Submitted That Met QC Criteria

January 28, 2021

Last Verified

December 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Distress Syndrome, Adult

Clinical Trials on no intervention

Subscribe